HT
Herriot Tabuteau
Executive
Chief Executive Officer of Axsome Therapeutics, Inc.
Notable Quotes
"The approval of our first-in-class medication for agitation associated with Alzheimer’s disease marks an important milestone for the millions of patients living with Alzheimer’s disease, their families, and their caregivers."View Story →